News
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Vectron Systems AG: Agreement on Severance and Compensation Payment between Vectron and Shift4 Group under the domination and profit and loss transfer agreement
Vectron Systems AG and Shift4 Group agree on severance and compensation payment under domination and profit transfer agreement, with fixed annual compensation payment set at EUR 0.47 per share -
-
COMMUNIQUÉ DE PRESSE
Galimedix Therapeutics to present positive pre-clinical data with amyloid beta aggregation modulator in development for oral Alzheimer’s disease treatment at AD/PD™ 2025 Conference
Galimedix Therapeutics to present positive pre-clinical data with amyloid beta aggregation modulator for oral Alzheimer's disease treatment at AD/PD(TM) 2025 Conference -
-
-
-
-
-